The funding, provided by investors including Qbic, will allow VUB and VIB spinout Confo Therapeutics to accelerate its drug discovery efforts and move towards clinical trials.

University of Twente-founded cartilage repair injection developer Hy2Care is currently targeting orthopaedic knee applications in veterinary and human healthcare settings.

The app-based electric bicycle rental service will use the proceeds from the round, which was led by Denso New Mobility Group, to expand in the US.

The Raptor Group-backed eSports brand will use the capital from the series A round to launch its audio product line and expand in the US and Asia.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Deskera has pushed its SIG and Cisco-backed series A round beyond $100m, after securing more than $40m in an extension led by Mirae Asset - Naver Asia Growth Fund.

Johns Hopkins University has invested in medical transport booking platform Roundtrip, a graduate of JHU-backed accelerator M-1 Ventures.

Bpifrance and HTGF are among the investors for Alentis Therapeutics’ series A round, proceeds of which will support the development of a therapy for liver fibrosis and cancer.

The enterprise and industrial provider has landed $31.1m in a Legend Capital-led round featuring parent company Neusoft.

The cell culture medium developer has reeled in $14.9m from investors including strategic partner WuXi Biologics in its series A-plus round.